Eva M Volf

A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.

A. Gottlieb, S. Au, P. Scheinman, 2012, Journal of drugs in dermatology : JDD.

Pediatric Psoriasis: An Emphasis on Treatment

S. Au, Eva M Volf, Eva M. Volf, 2010 .

Association between pediatric psoriasis and the metabolic syndrome.

A. Gottlieb, M. Natter, P. Lizzul, 2012, Journal of American Academy of Dermatology.

Prevalence of the Metabolic Syndrome in Children with Psoriatic Disease

A. Gottlieb, J. Kulig, P. Lizzul, 2013, Pediatric dermatology.

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

A. Gottlieb, P. Lizzul, Noori Kim, 2013, The Journal of dermatological treatment.

Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts.

A. Gottlieb, Eshan A. Patvardhan, J. Kuvin, 2011, Journal of Drugs in Dermatology.